MedPath

Virtual Reality in Cognitive Stimulation Therapy for Visually Impaired Older Individuals with Dementia

Not Applicable
Completed
Conditions
Dementia Patients
Registration Number
NCT06793384
Lead Sponsor
The Hong Kong Polytechnic University
Brief Summary

Both visual impairment and dementia are prevalent in the elderly population. Cognitive stimulation therapy (CST) is an evidence-based intervention for people with mild-to-moderate dementia. Virtual reality (VR) has been used in cognitive rehabilitation. However, the efficacy of CST and the feasibility of incorporating VR into therapy targeting people with dementia and visual impairment (PwDVI) have rarely been explored. The current pilot study addressed two issues: 1) To study the efficacy of conventional CST on PwDVI in different cognitive domains and 2) To explore the feasibility and efficacy of VR-CST on PwDVI in various cognitive domains.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
31
Inclusion Criteria
  1. Cantonese speakers;
  2. suspected or having a medical diagnosis of dementia, with the Montreal Cognitive Assessment 5-minute protocol (MoCA-5) score ranging from 2 to 17, which is equal to the Cantonese Mini Mental State Examination (MMSE) score ranging from 10 to 24 by using the conversion table from Wong et al,
  3. a diagnosis of mild to moderate visual impairment determined by an optometrist,
  4. no other disability including physical illness, learning disability and severe hearing impairment that may affect participation in group activity,
  5. not currently on psychiatric medication/cognitive intervention, (6) no history of other neurological diseases, and

(7) did not receive any prior CST.

Exclusion Criteria
  1. currently on psychiatric medication/cognitive intervention, (6) no history of other neurological diseases,
  2. currently on psychiatric medication/cognitive intervention, (6) no history of other neurological diseases,
  3. prior exposure to CST

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
The Hong Kong version of the Montreal Cognitive Assessment for the Visually Impaired (HKMoCA-VI)The assessment was administered three times 15 days before and after treatment.

It is a standarized assessment for global cognition for people with visual impairment.

Secondary Outcome Measures
NameTimeMethod
Holden Communication ScaleIt was administered once one week before and after the intervention.

It is a questionnaire to evaluate the participants' communication and social behavior from a caregiver's perspective. Ratings were given by the formal carers of the old age homes for the visually imapired.

Cantonese version of the Amsterdam-Nijmegan Everyday Language Test (CANELT)Three times 15 days before and after treatment

The test portrays 20 real-life situations encompassing different communicative functions, was conducted to evaluate functional communication quantitively. Scores were given based on the accuracy and completeness of the main concepts produced by the subjects.

Procedural description of making a ham-and-egg sandwichThe assessment was administered three times 15 days before and after treatment.

A picture depicting a loaf of bread, ham and an egg were presented to the subject and s/he will be asked to describe the procedures of making an egg-and-ham sandwich as detailed as possible.

Synonym judgementThe assessment was administered three times 15 days before and after treatment.

A pair of words were presented auditorily and the participants were asked to judge if the pair of words were synonymous or not.

Trial Locations

Locations (1)

The Hong Kong Society for the Blind

🇭🇰

Hong Kong, Hong Kong

© Copyright 2025. All Rights Reserved by MedPath